trending Market Intelligence /marketintelligence/en/news-insights/trending/FLz_Ew3u0vAcTBkARqI8bg2 content esgSubNav
In This List

ProPhase Labs director resigns; company out of Nasdaq compliance

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals


ProPhase Labs director resigns; company out of Nasdaq compliance

ProPhase Labs Inc. said the company is not in compliance with the Nasdaq listing rules following the resignation of Mark Burnett from its board.

The Doylestown, Pa.-based pharmaceutical company now has two independent directors on its board, one less than the minimum required by Nasdaq listing rules.

ProPhase Labs said it will start searching for an independent director to regain compliance with the Nasdaq listing requirements.